X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (82264) 82264
Book Review (16956) 16956
Publication (5178) 5178
Newsletter (4626) 4626
Conference Proceeding (717) 717
Book Chapter (269) 269
Book / eBook (132) 132
Newspaper Article (104) 104
Magazine Article (88) 88
Dissertation (69) 69
Reference (19) 19
Web Resource (19) 19
Transcript (14) 14
Journal / eJournal (8) 8
Presentation (8) 8
Trade Publication Article (8) 8
Government Document (7) 7
Data Set (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (66971) 66971
humans (66327) 66327
female (46408) 46408
oncology (37110) 37110
middle aged (33806) 33806
chemotherapy, adjuvant (33121) 33121
cancer (31868) 31868
aged (28612) 28612
male (28054) 28054
adult (26510) 26510
chemotherapy (22548) 22548
treatment outcome (18981) 18981
surgery (18413) 18413
adjuvant treatment (17074) 17074
prognosis (16457) 16457
neoplasm staging (16118) 16118
breast cancer (15904) 15904
adjuvant chemotherapy (15824) 15824
antineoplastic combined chemotherapy protocols - therapeutic use (15602) 15602
care and treatment (13636) 13636
retrospective studies (12132) 12132
radiotherapy (12021) 12021
combined modality therapy (11993) 11993
radiotherapy, adjuvant (11859) 11859
research (11750) 11750
survival (11440) 11440
breast neoplasms - drug therapy (11263) 11263
aged, 80 and over (10792) 10792
disease-free survival (9469) 9469
survival rate (9006) 9006
follow-up studies (8928) 8928
carcinoma (8866) 8866
therapy (8348) 8348
health aspects (8323) 8323
analysis (8315) 8315
medicine & public health (8017) 8017
breast neoplasms - pathology (8002) 8002
survival analysis (7611) 7611
antineoplastic agents - therapeutic use (7580) 7580
neoadjuvant therapy (7466) 7466
risk factors (6909) 6909
abridged index medicus (6367) 6367
tumors (6298) 6298
oncology, experimental (5992) 5992
radiation-therapy (5438) 5438
metastasis (5401) 5401
hematology, oncology and palliative medicine (5306) 5306
time factors (5214) 5214
lymphatic metastasis (5074) 5074
adolescent (4891) 4891
women (4875) 4875
breast neoplasms - surgery (4816) 4816
adjuvant therapy (4763) 4763
colorectal cancer (4573) 4573
cancer patients (4558) 4558
trial (4527) 4527
animals (4520) 4520
prospective studies (4455) 4455
randomized-trial (4353) 4353
fluorouracil - administration & dosage (4305) 4305
patient outcomes (4121) 4121
neoadjuvant chemotherapy (4081) 4081
recurrence (4047) 4047
drug therapy (3997) 3997
young adult (3853) 3853
antineoplastic combined chemotherapy protocols - adverse effects (3796) 3796
radiology, nuclear medicine & medical imaging (3772) 3772
kaplan-meier estimate (3754) 3754
radiation (3734) 3734
cisplatin - administration & dosage (3604) 3604
obstetrics & gynecology (3599) 3599
breast neoplasms - therapy (3510) 3510
patients (3507) 3507
diagnosis (3416) 3416
adenocarcinoma (3405) 3405
randomized controlled trials as topic (3370) 3370
breast neoplasms - mortality (3361) 3361
cisplatin (3346) 3346
multivariate analysis (3332) 3332
cancer therapies (3271) 3271
radiation therapy (3268) 3268
clinical trials (3231) 3231
proportional hazards models (3229) 3229
neoplasm recurrence, local (3225) 3225
fluorouracil (3223) 3223
management (3223) 3223
immunohistochemistry (3213) 3213
antineoplastic combined chemotherapy protocols - administration & dosage (3077) 3077
child (3060) 3060
tamoxifen (3047) 3047
medical research (2965) 2965
gastroenterology & hepatology (2956) 2956
adjuvant (2951) 2951
clinical trials as topic (2909) 2909
drug administration schedule (2758) 2758
medicine, general & internal (2750) 2750
risk assessment (2740) 2740
risk (2716) 2716
trastuzumab (2690) 2690
radiotherapy dosage (2685) 2685
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (97) 97
Online Resources - Online (17) 17
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Gerstein Science - Periodical Stacks (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Gerstein Science - Bindery (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Media Commons - Audio Visual (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (79398) 79398
German (2102) 2102
French (1794) 1794
Japanese (1658) 1658
Chinese (623) 623
Russian (497) 497
Spanish (407) 407
Italian (330) 330
Polish (196) 196
Hungarian (180) 180
Dutch (78) 78
Korean (65) 65
Danish (64) 64
Portuguese (63) 63
Czech (50) 50
Turkish (42) 42
Romanian (37) 37
Bulgarian (29) 29
Norwegian (25) 25
Ukrainian (23) 23
Finnish (18) 18
Swedish (18) 18
Hebrew (13) 13
Lithuanian (13) 13
Icelandic (7) 7
Serbian (7) 7
Slovak (6) 6
Croatian (4) 4
Slovenian (2) 2
Arabic (1) 1
Catalan (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chemotherapy, ISSN 1421-9794, 1968
Journal
Cancer, ISSN 0008-543X, 07/2012, Volume 118, Issue 13, pp. 3377 - 3386
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2010, Volume 119, Issue 2, pp. 212 - 216
Journal Article
JAMA, ISSN 0098-7484, 11/2016, Volume 316, Issue 18, pp. 1888 - 1896
IMPORTANCE: Standard dosing of chemotherapy based on body surface area results in marked interpatient variation in pharmacokinetics, toxic effects, and... 
MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | THERAPY | EUROPEAN-ORGANIZATION | CMF | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Epirubicin - administration & dosage | Austria | Sweden | Fluorouracil - administration & dosage | Antineoplastic Agents - adverse effects | Chemotherapy, Adjuvant - adverse effects | Adult | Female | Drug Administration Schedule | Neoplasm Recurrence, Local | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Quality of Life | Breast Neoplasms - mortality | Aged | Germany | Women | Chemotherapy | Usage | Adjuvant treatment | Clinical trials | Breast cancer | Diagnosis | Research | Comparative analysis | Health aspects | Cancer | Womens health | Risk factors | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3138 - 3145
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2010, Volume 46, Issue 13, pp. 2422 - 2431
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 687 - 697
Summary Background Trastuzumab, a monoclonal antibody against human epidermal growth factor receptor 2 (HER2; also known as ERBB2), was investigated in... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | SUPPORTIVE CARE | MEDICINE, GENERAL & INTERNAL | METASTATIC BREAST-CANCER | ADVANCED ESOPHAGOGASTRIC CANCER | GENE AMPLIFICATION | 1ST-LINE THERAPY | HER2 | FLUOROURACIL | III TRIAL | PLUS | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Middle Aged | Stomach Neoplasms - metabolism | Male | Antineoplastic Agents - administration & dosage | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized | Adenocarcinoma - metabolism | Fluorouracil - administration & dosage | Female | Drug Therapy, Combination | Receptor, ErbB-2 - biosynthesis | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Esophagogastric Junction | Antibodies, Monoclonal - administration & dosage | Survival Analysis | Aged | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Trastuzumab | Adenocarcinoma - mortality | Chemotherapy | Gastrointestinal cancer | Patient outcomes | Drug therapy, Combination | Drug therapy | Methods | Cancer | Voice recognition | Heart failure | Clinics | Heart attacks | Breast cancer | Blood pressure | Clinical medicine | Angina pectoris | Cancer therapies | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Annals of Surgery, ISSN 0003-4932, 11/2013, Volume 258, Issue 5, pp. 731 - 742
OBJECTIVES:We analyzed the impact of chemotherapy-related liver injuries (CALI), pathological tumor regression grade (TRG), and micrometastases on long-term... 
Neoadjuvant chemotherapy | Adjuvant chemotherapy | Tumor regression grade | Chemotherapy-related liver injuries | Sinusoidal dilatation | Sinusoidal obstruction syndrome | Colorectal liver metastases | Liver surgery | Survival | Preoperative chemotherapy | Prognostic factors | Steatosis | Microscopic biliary invasion | Body mass index | Nodular regenerative hyperplasia | Long-term outcome | Micrometastases | Pathological tumor response to chemotherapy | Steatohepatitis | Microvascular invasion | SURGERY | adjuvant chemotherapy | RECEIVING PREOPERATIVE CHEMOTHERAPY | sinusoidal obstruction syndrome | microvascular invasion | colorectal liver metastases | prognostic factors | OXALIPLATIN | tumor regression grade | CANCER | microscopic biliary invasion | preoperative chemotherapy | INTRAHEPATIC MICROMETASTASES | nodular regenerative hyperplasia | steatosis | steatohepatitis | HEPATECTOMY | body mass index | micrometastases | pathological tumor response to chemotherapy | survival | liver surgery | HEPATIC RESECTION | chemotherapy-related liver injuries | sinusoidal dilatation | neoadjuvant chemotherapy | long-term outcome | BODY-MASS INDEX | CARCINOMA | Prognosis | Humans | Male | Fatty Liver - chemically induced | Bevacizumab | Neoplasm Micrometastasis | Antineoplastic Agents - adverse effects | Female | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Hepatectomy - methods | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Survival Rate | Treatment Outcome | Combined Modality Therapy | Hepatic Veno-Occlusive Disease - chemically induced | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Summary Background Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer | Index Medicus
Journal Article